Substance active (DCI)
- crisantaspase recombinante
Informations techniques
Exploitant
JAZZ PHARMACEUTICALS
Présentation
ENRYLAZE 10 mg/0,5 mL, solution injectable / pour perfusion
3 flacons en verre de 0,5 ml (CIP : 34009 550 986 8 3)
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
GJaeSRa0qPtyTNvy
Écouter
Français